ARCHIVES

HPV Vaccine Cervarix Active In 100% Of Women In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

The March: Research Task Force Calls For $10 Billion For NCI In 5 Years

October 23, 1998

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

HHS Approves States Plans For Breast, Cervical Cancer Treatment For Uninsured.

April 6, 2001